May 20, 2020 / 02:50PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. Good morning. Thanks for joining us for our next session here at the UBS Virtual Global Healthcare Conference. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst, and I'm really pleased to be joined by management from LivaNova.
So today, we're going to have on the line, Damien McDonald, the CEO. We also got Thad Huston, CFO; and Melissa Farina who leads the IR function at the company. So a lot of opportunity to get insights from assortment of members of the management team. And as everybody knows with these sessions, it will be about a 40-minute Q&A, fireside chat. And if you want to submit questions, you can either e-mail me or push them through the webcast application.
Questions and Answers:
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & DevicesSo maybe just to get started, I'll kick it over with a bigger picture question and ask